Biogen Pours Cold Water On Cross Country Spinraza Pricing Talks With Norway And Denmark
Executive Summary
Biogen is reluctant to enter joint talks with Norway and Denmark over Spinraza, but the company expects that cross-country pricing and reimbursement collaboration will become a fixture.